170 related articles for article (PubMed ID: 21735820)
1. [UDP-glucuronyltransferases in detoxification and activation metabolism of endogenous compounds and xenobiotics].
Fedejko B; Mazerska Z
Postepy Biochem; 2011; 57(1):49-62. PubMed ID: 21735820
[TBL] [Abstract][Full Text] [Related]
2. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein.
Green MD; Bélanger G; Hum DW; Bélanger A; Tephly TR
Drug Metab Dispos; 1997 Dec; 25(12):1389-94. PubMed ID: 9394029
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.
Green MD; King CD; Mojarrabi B; Mackenzie PI; Tephly TR
Drug Metab Dispos; 1998 Jun; 26(6):507-12. PubMed ID: 9616184
[TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferases and clinical drug-drug interactions.
Kiang TK; Ensom MH; Chang TK
Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
[TBL] [Abstract][Full Text] [Related]
6. [Human drug metabolizing enzymes. II. Conjugation enzymes].
Vereczkey L; Jemnitz K; Gregus Z
Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
[TBL] [Abstract][Full Text] [Related]
7. [Glucuronidation of antitumour therapeutics--detoxification, mechanism of resistance or prodrug formation?].
Mróz A; Mazerska Z
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1462-77. PubMed ID: 27259218
[TBL] [Abstract][Full Text] [Related]
8. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.
Knights KM; Miners JO
Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654
[TBL] [Abstract][Full Text] [Related]
9. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.
Ritter JK
Chem Biol Interact; 2000 Dec; 129(1-2):171-93. PubMed ID: 11154740
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.
Green MD; Tephly TR
Drug Metab Dispos; 1998 Sep; 26(9):860-7. PubMed ID: 9733664
[TBL] [Abstract][Full Text] [Related]
12. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.
Green MD; Tephly TR
Drug Metab Dispos; 1996 Mar; 24(3):356-63. PubMed ID: 8820428
[TBL] [Abstract][Full Text] [Related]
14. Carboxylic acid drug-induced DNA nicking in HEK293 cells expressing human UDP-glucuronosyltransferases: role of acyl glucuronide metabolites and glycation pathways.
Southwood HT; DeGraaf YC; Mackenzie PI; Miners JO; Burcham PC; Sallustio BC
Chem Res Toxicol; 2007 Oct; 20(10):1520-7. PubMed ID: 17880178
[TBL] [Abstract][Full Text] [Related]
15. Drug and Chemical Glucosidation by Control Supersomes and Membranes from
Chau N; Kaya L; Lewis BC; Mackenzie PI; Miners JO
Drug Metab Dispos; 2019 Mar; 47(3):271-278. PubMed ID: 30541877
[TBL] [Abstract][Full Text] [Related]
16. N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.
Kaivosaari S; Finel M; Koskinen M
Xenobiotica; 2011 Aug; 41(8):652-69. PubMed ID: 21434773
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
Green MD; Oturu EM; Tephly TR
Drug Metab Dispos; 1994; 22(5):799-805. PubMed ID: 7835232
[TBL] [Abstract][Full Text] [Related]
18. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1.
King CD; Green MD; Rios GR; Coffman BL; Owens IS; Bishop WP; Tephly TR
Arch Biochem Biophys; 1996 Aug; 332(1):92-100. PubMed ID: 8806713
[TBL] [Abstract][Full Text] [Related]
19. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
20. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
